2seventy bio, Inc. Contracts & Agreements
32 Contracts & Agreements
- Business Finance (5 contracts)
- Business Operations (2)
- Human Resources (15)
- Intellectual Property (5)
- Uncategorized (5)
- Release and Equity Agreement, by and between 2seventy bio, Inc. and Philip Gregory (Filed With SEC on March 18, 2024)
- Second Amendment to License Agreement, dated January 16, 2024, by and between 2seventy bio, Inc. and the National Institutes of Health (Filed With SEC on March 7, 2024)
- Executive Employment Agreement between 2seventy bio, Inc. and Victoria Eatwell, dated as of January 29, 2024 (Filed With SEC on January 30, 2024)
- Executive Employment Agreement between 2seventy bio, Inc. and William Baird, dated as of January 29, 2024 (Filed With SEC on January 30, 2024)
- Transitional Services Agreement between 2seventy bio, Inc. and Nick Leschly, dated as of January 29, 2024 (Filed With SEC on January 30, 2024)
- Second Amendment to Amended and Restated Co-Development, Co-Promote and Profit Share Agreement, between 2seventy bio, Inc., Celgene Corporation and Celgene Investment Company LLC,... (Filed With SEC on August 14, 2023)
- License Agreement by and between bluebird bio, Inc. and Institut Pasteur, dated September 8, 2011, as amended (Filed With SEC on May 10, 2023)
- Consulting Agreement between 2seventy bio, Inc. and Nicola Heffron, dated February 21, 2023 (Filed With SEC on March 16, 2023)
- Severance Agreement between Globalization Partners Switzerland SA and Nicola Heffron, dated February 17, 2023 (Filed With SEC on March 16, 2023)
- Underwriting Agreement, dated as of February 28, 2023, by and between the Company and Goldman Sachs & Co. LLC, Cowen and Company, LLC, and SVB Securities LLC, as representatives... (Filed With SEC on March 1, 2023)
- Sales Agreement, dated November 18, 2022 between 2seventy bio, Inc. and Cowen and Company, LLC (Filed With SEC on November 18, 2022)
- Amendment to License Agreement, dated April 25, 2022, by and between 2seventy bio, Inc. and the National Institutes of Health (Filed With SEC on May 12, 2022)
- Patent License Agreement, dated August 31, 2015, by and between bluebird bio, Inc. and the National Institutes of Health (Filed With SEC on May 12, 2022)
- Second Addendum to Executive Employment Agreement between Globalization Partners Switzerland SA and Nicola Heffron, dated as of March 25, 2022 (Filed With SEC on May 12, 2022)
- First Addendum Executive Employment Agreement between Globalization Partners Switzerland SA and Nicola Heffron, dated as of March 7, 2022 (Filed With SEC on May 12, 2022)
- Amendment to Executive Employment Agreement between Globalization Partners Switzerland SA and Nicola Heffron, dated as of December 8, 2021 (Filed With SEC on March 22, 2022)
- Executive Employment Agreement between Globalization Partners Switzerland SA and Nicola Heffron, dated as of December 1, 2021 (Filed With SEC on March 22, 2022)
- Letter Agreement between 2seventy bio, Inc. and Nicola Heffron, dated as of November 8, 2021 (Filed With SEC on March 22, 2022)
- 2seventy bio, Inc. Non-Employee Director Compensation Policy (Filed With SEC on March 22, 2022)
- Description of Securities (Filed With SEC on March 22, 2022)
- Form of Registration Rights Agreement (Filed With SEC on March 16, 2022)
- Form of Share Purchase Agreement (Filed With SEC on March 16, 2022)
- Separation Agreement, dated as of November 3, 2021, by and between bluebird bio, Inc. and 2seventy bio, Inc (Filed With SEC on November 4, 2021)
- Executive Employment Agreement, effective as of November 4, 2021, by and between 2seventy bio, Inc. and Philip Gregory (Filed With SEC on November 4, 2021)
- Executive Employment Agreement, effective as of November 4, 2021, by and between 2seventy bio, Inc. and William Baird (Filed With SEC on November 4, 2021)
- Executive Employment Agreement, effective as of November 4, 2021, by and between 2seventy bio, Inc. and Nick Leschly (Filed With SEC on November 4, 2021)
- Assumption Agreement, dated as (Filed With SEC on November 4, 2021)
- Transition Services Agreement, dated as of November 3, 2021, by and between 2seventy bio, Inc. and bluebird bio, Inc (Filed With SEC on November 4, 2021)
- Transition Services Agreement, dated as of November 3, 2021, by and between bluebird bio, Inc. and 2seventy bio, Inc (Filed With SEC on November 4, 2021)
- Intellectual Property License Agreement, dated as of November 3, 2021, by and between bluebird bio, Inc. and 2seventy bio, Inc (Filed With SEC on November 4, 2021)
- Employee Matters Agreement, dated as of November 3, 2021, by and between bluebird bio, Inc. and 2seventy bio, Inc (Filed With SEC on November 4, 2021)
- Tax Matters Agreement, dated as of November 3, 2021, by and between bluebird bio, Inc. and 2seventy bio, Inc (Filed With SEC on November 4, 2021)